MedChem 2021

Medicinal Chemistry in Belgium: Innovation and Success Stories

Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV

 Liege, Belgium    November 19, 2021

Programme


08:00

Registration

08:50

Opening

Session Chair

Prof Bernard PIROTTE
ULIÈGE, Liège, Belgium
09:00

Title to be announced

Dr Gilles BERGER
ULB, Brussels, Belgium
09:30

Purines and Trypanosomatids – a Neglected Match for New Therapeutics?

Dr Fabian HULPIA
JANSSEN PHARMACEUTICA, Beerse, Belgium
10:00

Modulating Protein-Protein Interactions by Means of Rigidified Peptidomimetics

Prof. Steven BALLET
VRIJE UNIVERSITEIT BRUSSEL, Brussels, Belgium
10:30

Coffee break and Exhibition

11:00

Discovery of GLPG2451, a novel Potentiator for the Treatment of Cystic Fibrosis

Dr Hans KELGTERMANS
GALAPAGOS NV, Mechelen, Belgium
11:30

Discovery of Novel Small Molecule Modulators of TNFα Binding and Signalling

Dr Dan BROOKINGS
UCB, Slough, United Kingdom
12:00

ConfoBody Technology Suite: Unleashing the Full Therapeutic Potential of GPCR Targets

Dr Christel MENET
CONFO THERAPEUTICS, Brussels, Belgium
12:30

Lunch, Exhibition and Poster session

Session Chair

Prof. Serge VAN CALENBERGH
UGENT, Ghent, Belgium
14:00

UAMC1110 as the Starting Point for a new Generation of Diagnostics and Therapeutics Targeting Fibroblast Activation Protein (FAP)

Prof. Pieter VAN DER VEKEN
UANTWERP, Antwerp, Belgium
14:30

Step by Step Towards Fully Modified Aptamers | Chemistry Europe Talk

Prof. Eveline LESCRINIER
REGA INSTITUTE - KU LEUVEN, Leuven, Belgium
15:00

Scaffold Development for the Inhibition of FXIIa, a Promising Therapeutic Target

Dr Lionel POCHET
UNAMUR, Namur, Belgium
15:30

Coffee break and Exhibition

16:00

Meddling with Cell Death Control: Development of MCL-1 Inhibitors for the Treatment of Cancer

Dr Frederik ROMBOUTS
JANSSEN PHARMACEUTICA, Beerse, Belgium
16:30

Interrogating the Lactate Dehydrogenase (LDH) Tetramerization Site with (stapled) Peptides

Prof. Raphaël FREDERICK
UCLOUVAIN, Brussels-Woluwe, Belgium
17:00

Development of Positive Allosteric Modulators for Glutamate Ionotropic Receptors

Dr Pierre FRANCOTTE
ULIÈGE, Liège, Belgium
17:30

Closing Remarks